SUPPLY AGREEMENTSupply Agreement • October 28th, 2009 • Raptor Pharmaceuticals Corp. • Pharmaceutical preparations • New York
This Supply Agreement (“Agreement”) is effective as of this 20th day of July, 2009 (“Effective Date”), by and between Mylan Pharmaceuticals Inc., a corporation duly organized under the laws of the state of West Virginia (MYLAN”), and Raptor Therapeutics Inc., a corporation duly organized under the laws of Delaware (“RAPTOR”). RAPTOR and MYLAN may be referred to herein as the “Party” or “Parties.”
Collaboration and License AgreementCollaboration and License Agreement • October 28th, 2009 • Raptor Pharmaceuticals Corp. • Pharmaceutical preparations • New Jersey
with an office and place of business at 340 Kingsland Street, Nutley, New Jersey 07110, U.S.A. (“Roche Nutley”; Roche Basel and Roche Nutley together referred to as “Roche”)
WARRANT AMENDMENT AND SUBSCRIPTION AGREEMENTWarrant Amendment and Subscription Agreement • October 28th, 2009 • Raptor Pharmaceuticals Corp. • Pharmaceutical preparations • Delaware
This Warrant Amendment and Subscription Agreement (this “Agreement”) is entered into as of July 17, 2009 between Raptor Pharmaceuticals Corp., a Delaware corporation (the “Company”), and the undersigned warrantholder (“Investor”), with respect to the exercise of the those warrants (collectively, the ”Warrants”) to purchase shares of the Company’s common stock, par value $.001 per share (“Common Stock”) issued to Investor in connection with the Company’s private placement of units (consisting of the Company’s common stock and warrants) pursuant to the terms of that certain Securities Purchase Agreement, dated May 21, 2008, by and among the Company, the Investor, and the other parties named therein, as amended by that certain Amendment to Securities Purchase Agreement, dated May 21, 2008 (collectively, the “Purchase Agreement”). Pursuant to this Agreement, Investor will purchase the number of shares of Common Stock set forth on the subscription forms of such Warrants (the “Subscription F
RAPTOR PHARMACEUTICALS CORP. SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 28th, 2009 • Raptor Pharmaceuticals Corp. • Pharmaceutical preparations • Delaware
This Securities Purchase Agreement (this “Agreement”) is made as of August 21, 2009 (the “Effective Date”), by and among Raptor Pharmaceuticals Corp., a Delaware corporation (the Company”), and the individuals and entities identified on the signature pages hereto (each, a “Purchaser” and, collectively, the “Purchasers”).
